Vident Investment Advisory’s Sabra Healthcare REIT SBRA Stock Holding History

Vident Investment Advisory’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,628	Closed	-$196K	–	853
2023 Q2	$196K	Buy	16,628 +6,170	+59%	+$70.2K	0.01%	1067
2023 Q1	$120K	Sell	10,458 -84,848	-89%	-$1.05M	﹤0.01%	1156
2022 Q4	$1.18M	Buy	+95,306	New	+$1.22M	0.04%	445
2022 Q1	–	Sell	-28,854	Closed	-$391K	–	1338
2021 Q4	$391K	Buy	28,854 +348	+1%	+$4.92K	0.01%	993
2021 Q3	$420K	Buy	28,506 +18,128	+175%	+$306K	0.01%	924
2021 Q2	$189K	Buy	10,378 +254	+3%	+$4.52K	0.01%	1068
2021 Q1	$176K	Buy	+10,124	New	+$178K	0.01%	972
2020 Q3	–	Sell	-18,312	Closed	-$264K	–	926
2020 Q2	$264K	Sell	18,312 -1,856	-9%	-$24.4K	0.01%	784
2020 Q1	$220K	Buy	+20,168	New	+$372K	0.01%	744
2018 Q2	–	Sell	-11,686	Closed	-$205K	–	962
2018 Q1	$205K	Buy	+11,686	New	+$206K	0.01%	861

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Vident Investment Advisory's SBRA Position: Q3 2023 in Review

Vident Investment Advisory sold out of Sabra Healthcare REIT (SBRA) in Q3 2023, closing a stake of 16,628 shares — an estimated $196K sold.

Vident Investment Advisory first reported a position in SBRA in Q1 2018 and held it in 10 quarters. The position peaked at $1.18M in Q4 2022. 329 funds tracked by Wall St. Rank hold SBRA as of Q3 2023.

Vident Investment Advisory reported no remaining Sabra Healthcare REIT position as of Q3 2023 after selling out during the quarter.
Vident Investment Advisory sold 16,628 Sabra Healthcare REIT shares in Q3 2023, an estimated $196K.
Vident Investment Advisory first reported a position in Sabra Healthcare REIT in Q1 2018 and held it in 10 quarters.
Vident Investment Advisory's Sabra Healthcare REIT position peaked at $1.18M in Q4 2022.
329 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.